News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
667,950 Results
Type
Article (62487)
Company Profile (77)
Press Release (605377)
Multimedia
Podcasts (102)
Webinars (21)
Section
Business (174424)
Career Advice (2752)
Deals (32554)
Drug Delivery (116)
Drug Development (77285)
Employer Resources (154)
FDA (15175)
Job Trends (13963)
News (306417)
Policy (29169)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (2)
Academia (2914)
Academic (2)
Accelerated approval (35)
Adcomms (28)
Allergies (145)
Alliances (43384)
ALS (169)
Alzheimer's disease (1612)
Antibody-drug conjugate (ADC) (297)
Approvals (15455)
Artificial intelligence (537)
Autoimmune disease (168)
Automation (41)
Bankruptcy (293)
Best Places to Work (10859)
BIOSECURE Act (16)
Biosimilars (181)
Biotechnology (55)
Bladder cancer (158)
Brain cancer (61)
Breast cancer (633)
Cancer (4771)
Cardiovascular disease (398)
Career advice (2350)
Career pathing (40)
CAR-T (290)
CDC (48)
Celiac Disease (2)
Cell therapy (772)
Cervical cancer (36)
Clinical research (66221)
Collaboration (1673)
Company closure (5)
Compensation (733)
Complete response letters (59)
COVID-19 (2688)
CRISPR (97)
C-suite (926)
Cystic fibrosis (144)
Data (6212)
Decentralized trials (2)
Denatured (41)
Depression (138)
Diabetes (475)
Diagnostics (6491)
Digital health (45)
Diversity (13)
Diversity, equity & inclusion (40)
Drug discovery (252)
Drug pricing (185)
Drug shortages (25)
Duchenne muscular dystrophy (217)
Earnings (63521)
Editorial (60)
Employer branding (18)
Employer resources (138)
Events (98961)
Executive appointments (1044)
FDA (18328)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (1471)
Gene editing (206)
Generative AI (46)
Gene therapy (578)
GLP-1 (913)
Government (4720)
Grass and pollen (7)
Guidances (381)
Healthcare (18274)
HIV (60)
Huntington's disease (40)
IgA nephropathy (80)
Immunology and inflammation (226)
Immuno-oncology (58)
Indications (113)
Infectious disease (2953)
Inflammatory bowel disease (194)
Inflation Reduction Act (13)
Influenza (118)
Intellectual property (252)
Interviews (532)
IPO (14915)
IRA (45)
Job creations (3428)
Job search strategy (1948)
JPM (62)
Kidney cancer (17)
Labor market (76)
Layoffs (592)
Leadership (37)
Legal (6485)
Liver cancer (84)
Longevity (13)
Lung cancer (636)
Lymphoma (369)
Machine learning (40)
Management (54)
Manufacturing (756)
MASH (165)
Medical device (13050)
Medtech (13104)
Mergers & acquisitions (18760)
Metabolic disorders (1218)
Multiple sclerosis (154)
NASH (13)
Neurodegenerative disease (311)
Neuropsychiatric disorders (88)
Neuroscience (2828)
Neurotech (1)
NextGen: Class of 2026 (6384)
Non-profit (4356)
Now hiring (21)
Obesity (553)
Opinion (295)
Ovarian cancer (162)
Pain (203)
Pancreatic cancer (229)
Parkinson's disease (279)
Partnered (33)
Patents (510)
Patient recruitment (517)
Peanut (59)
People (61329)
Pharmaceutical (19)
Pharmacy benefit managers (27)
Phase 1 (20893)
Phase 2 (29183)
Phase 3 (21299)
Pipeline (5328)
Policy (277)
Postmarket research (2476)
Preclinical (8886)
Press Release (67)
Prostate cancer (244)
Psychedelics (42)
Radiopharmaceuticals (281)
Rare diseases (837)
Real estate (6039)
Recruiting (66)
Regulatory (22388)
Reports (41)
Research institute (2472)
Resumes & cover letters (408)
Rett syndrome (28)
RNA editing (15)
RSV (70)
Schizophrenia (147)
Series A (242)
Series B (185)
Service/supplier (8)
Sickle cell disease (95)
Special edition (16)
Spinal muscular atrophy (155)
Sponsored (43)
Startups (3384)
State (1)
Stomach cancer (12)
Supply chain (87)
Tariffs (67)
The Weekly (59)
Vaccines (981)
Venture capital (78)
Weight loss (342)
Women's health (87)
Worklife (21)
Date
Today (132)
Last 7 days (613)
Last 30 days (2194)
Last 365 days (28397)
2026 (3914)
2025 (28698)
2024 (32297)
2023 (36353)
2022 (46630)
2021 (51583)
2020 (50746)
2019 (44793)
2018 (34068)
2017 (30722)
2016 (30075)
2015 (35457)
2014 (28387)
2013 (24985)
2012 (26251)
2011 (26476)
2010 (24973)
Location
Africa (887)
Alabama (86)
Alaska (6)
Arizona (241)
Arkansas (15)
Asia (39431)
Australia (7081)
California (10453)
Canada (3122)
China (1062)
Colorado (443)
Connecticut (447)
Delaware (331)
Europe (91982)
Florida (1584)
Georgia (351)
Hawaii (3)
Idaho (59)
Illinois (880)
India (68)
Indiana (484)
Iowa (22)
Japan (416)
Kansas (119)
Kentucky (39)
Louisiana (26)
Maine (75)
Maryland (1286)
Massachusetts (7377)
Michigan (336)
Minnesota (564)
Mississippi (6)
Missouri (138)
Montana (34)
Nebraska (26)
Nevada (114)
New Hampshire (77)
New Jersey (2909)
New Mexico (30)
New York (2849)
North Carolina (1435)
North Dakota (10)
Northern California (5050)
Ohio (323)
Oklahoma (23)
Oregon (42)
Pennsylvania (2064)
Puerto Rico (24)
Rhode Island (45)
South America (1189)
South Carolina (54)
South Dakota (1)
Southern California (4161)
Tennessee (170)
Texas (1671)
United States (37551)
Utah (324)
Vermont (1)
Virginia (260)
Washington D.C. (66)
Washington State (862)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
667,950 Results for "university of montreal".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic Cancer Alpha DaRT® Study
January 7, 2026
·
7 min read
Press Releases
Novartis Canada Unveils 2025 Health Equity Initiative Winners, Awarding Over $560,000 at Montreal Ceremony with Federal Health Minister, the Honourable Marjorie Michel, in Attendance
November 28, 2025
·
5 min read
Press Releases
Shining a spotlight on the Montreal Chest Institute
February 28, 2025
·
5 min read
Press Releases
Ability Biotherapeutics Moves to Inspire Bio Innovations in Montreal, Pioneering the New Generation of Targeted Antibodies
April 29, 2025
·
4 min read
Press Releases
First-of-its-kind Universal Clearance Establishes Maximum Regulatory Access to the Bezier Parametric Curve Spinal Rod System for Patients and Surgeons
February 5, 2026
·
2 min read
Press Releases
Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds: Highlights Strong Safety, Functional Gains, and Florida Access Pathway
Session led by neurosurgeon Dr. Fraser Henderson and Hemostemix CEO Thomas Smeenk for the University of Florida’s Department of Surgery, Division of Vascular Surgery & Endovascular Therapy (Gainesville)
November 13, 2025
·
10 min read
Business
Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada
Novocure announced it has opened a new office in Montreal to expand and support its growing business in Canada.
November 15, 2022
·
6 min read
Montreal team is developing a breakthrough brain implant to boost mobility after spinal cord injuries
A presidential scholar from Pennsylvania is in Montreal this summer, applying her expertise to help a state-of-the-art lab at École Polytechnique de Montréal advance a breakthrough medical device that enables people with spinal cord injuries to move their limbs.
July 24, 2023
·
4 min read
FDA
The Montreal Heart Institute Welcomes FDA Approval of Colchicine for the Treatment of Cardiovascular Diseases
The Montreal Heart Institute (MHI) welcomes the approval by the United States Food and Drug Administration (FDA) of colchicine for cardiovascular prevention.
June 23, 2023
·
2 min read
Pharm Country
University of Montreal’s School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery
Helius Medical Technologies, Inc. announced it has signed an agreement with the School of Rehabilitation at the Université de Montréal for the purchase of ten PoNS devices to be used in a research project linked to stroke recovery.
September 20, 2023
·
6 min read
1 of 66,795
Next
